ArticleJournal of experimental & clinical cancer research : CR2021

Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway.

Feng Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.